Cancer of the Uterine Cervix

被引:21
作者
Eliane Duarte-Franco
Eduardo L Franco
机构
[1] Departments of Oncology and Family Medicine, McGill University, Montreal
[2] Departments of Oncology and Epidemiology and Biostatistics, McGill University, Montreal
关键词
Cervical Cancer; Cervical Cancer Screening; Cervical Intraepithelial Neoplasia; Cervical Neoplasia; Invasive Cervical Cancer;
D O I
10.1186/1472-6874-4-S1-S13
中图分类号
学科分类号
摘要
Health issue: Cervical cancer is one of the most common malignant diseases of women; it is diagnosed in almost half a million women every year and half as many die from it annually. In Canada and other industrialized countries, its incidence has decreased due to cytology screening. However, invasive cases still occur, particularly among immigrant groups and native Canadian women. Although incidence of squamous cell carcinomas has decreased, the proportion of adenocarcinomas has increased because Pap cytology is ineffective to detect these lesions. Key findings: In Canada, cervical cancer will cause an estimated 11,000 person-years of life lost. In most Canadian provinces, early detection is dependent on opportunistic screening. Primary prevention can be achieved through health education (sexual behavior modification) and vaccination to prevent infection from Human Papillomavirus (HPV). The initial results from vaccination trials are encouraging but wide scale use is more than a decade away. Data gaps and recommendations: Most cases of cervical cancer occur because the Pap smear was either false negative, was not done or not done often enough. Appropriate recommendations and guidelines exist on implementation of cytology-based programs. However, most Canadian women do not have access to organized screening. Further research is needed to 1) evaluate automated cytology systems; 2) define appropriate management of precursor lesions and 3) deliver definitive evidence of HPV testing efficacy in long-term follow-up studies with invasive cancer as an outcome and 4) provide Canadian data to justify augmenting or modifying current programs to use HPV testing in secondary triage of equivocal Pap smears. © Duarte-Franco and Franco; licensee BioMed Central Ltd 2004. This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
引用
收藏
相关论文
共 71 条
[1]  
Canadian cancer statistics 2003, (2003)
[2]  
Ferlay J., Bray F., Pisani P., Parkin D.M., GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. Version 1.0, IARC CancerBase, (2001)
[3]  
Parkin D.M., Pisani P., Ferlay J., Estimates of the worldwide incidence of 25 major cancers in 1990, Int J Cancer, 80, pp. 827-841, (1999)
[4]  
Ries L.A.G., Eisner M.P., Kosary C.L., Hankey B.F., Miller B.A., Clegg L., Edwards B.K., SEER cancer statistics review, 1973–1998, (2000)
[5]  
Canadian cancer statistics 1991, (1991)
[6]  
Canadian cancer statistics 2001, (2001)
[7]  
Duarte E., Franco E.L., Determinants of patient survival in cervical cancer: an overview, CME Journal of Gynecologic Oncology, 6, pp. 73-183, (2001)
[8]  
Gorey K.M., Holowary E.J., Fehringer G., Laukkanen E., Moskowitz A., Webster D.J., Et al., An international comparison of cancer survival: Toronto, Ontario, and Detroit, Michigan, metropolitan areas, Am J Public Health, 87, pp. 1156-1163, (1997)
[9]  
Mackillop W.J., Zhang-Salomons J., Groome P.A., Paszat L., Holowaty E., Socioeconomic status and cancer survival in Ontario, J Clin Oncol, 15, pp. 1680-1689, (1997)
[10]  
Boyd C., Zhang-Salomons J.Y., Groome P.A., Mackillop W.J., Associations between community income and cancer survival in Ontario, Canada, and the United States, J Clin Oncol, 17, pp. 2244-2255, (1999)